Israeli hospital: 98% of staff who got 2nd shot have high-level COVID antibodies - The Times of Israel

A new serological study conducted at an Israeli hospital found that 98 percent of hospital workers who received the second dose of the coronavirus vaccine have developed a high level of antibodies to fight off the virus.

The study of 102 samples, taken a week after Israel began administering the second dose — when the vaccine is expected to reach peak effectiveness — showed most vaccinated people had higher antibody counts than those who have recovered from COVID-19.

The hospital said that a week after receiving the final dose, antibodies jumped to a level six to 20 times higher than after the first shot.

Proponents say the deal could allow Israel to become the first country to vaccinate most of its population, while providing valuable research that could help the rest of the world.

Does The Times of Israel give you valuable insight into Israel and the Jewish world.

If so, please join The Times of Israel Community.

But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community

For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members